521 related articles for article (PubMed ID: 25320371)
41. [Etiopathogenesis and therapeutic trends in adult T-cell leukemia associated with HTLV-I retrovirus].
D'Onofrio C; Bonmassar E
Clin Ter; 1992 Feb; 140(2):155-67. PubMed ID: 1373677
[TBL] [Abstract][Full Text] [Related]
42. Adult T-cell leukemia-lymphoma in a pregnant woman diagnosed as a human T-cell lymphotropic virus type 1 carrier.
Fuchi N; Miura K; Imaizumi Y; Hasegawa H; Yanagihara K; Miyazaki Y; Masuzaki H
J Obstet Gynaecol Res; 2016 Mar; 42(3):336-40. PubMed ID: 26663442
[TBL] [Abstract][Full Text] [Related]
43. Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms.
Taniguchi Y; Nosaka K; Yasunaga J; Maeda M; Mueller N; Okayama A; Matsuoka M
Retrovirology; 2005 Oct; 2():64. PubMed ID: 16242045
[TBL] [Abstract][Full Text] [Related]
44. Human T-cell leukemia virus type I Tax genotype analysis in Okinawa, the southernmost and remotest islands of Japan: Different distributions compared with mainland Japan and the potential value for the prognosis of aggressive adult T-cell leukemia/lymphoma.
Sakihama S; Saito M; Kuba-Miyara M; Tomoyose T; Taira N; Miyagi T; Hayashi M; Kinjo S; Nakachi S; Tedokon I; Nishi Y; Tamaki K; Morichika K; Uchihara JN; Morishima S; Karube KN; Tanaka Y; Masuzaki H; Fukushima T
Leuk Res; 2017 Oct; 61():18-24. PubMed ID: 28866351
[TBL] [Abstract][Full Text] [Related]
45. [Adult T cell leukemia/lymphoma (ATL)].
Tanosaki R
Nihon Rinsho; 2003 Sep; 61(9):1592-5. PubMed ID: 14515729
[TBL] [Abstract][Full Text] [Related]
46. Tumor necrosis factor alpha polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers.
Tsukasaki K; Miller CW; Kubota T; Takeuchi S; Fujimoto T; Ikeda S; Tomonaga M; Koeffler HP
Cancer Res; 2001 May; 61(9):3770-4. PubMed ID: 11325850
[TBL] [Abstract][Full Text] [Related]
47. Foxp3 expression on normal and leukemic CD4+CD25+ T cells implicated in human T-cell leukemia virus type-1 is inconsistent with Treg cells.
Abe M; Uchihashi K; Kazuto T; Osaka A; Yanagihara K; Tsukasaki K; Hasegawa H; Yamada Y; Kamihira S
Eur J Haematol; 2008 Sep; 81(3):209-17. PubMed ID: 18510697
[TBL] [Abstract][Full Text] [Related]
48. HTLV-1 and associated adult T-cell leukemia/lymphoma.
Mahieux R; Gessain A
Rev Clin Exp Hematol; 2003 Dec; 7(4):336-61. PubMed ID: 15129647
[TBL] [Abstract][Full Text] [Related]
49. Adult T-cell leukemia/lymphoma.
Qayyum S; Choi JK
Arch Pathol Lab Med; 2014 Feb; 138(2):282-6. PubMed ID: 24476526
[TBL] [Abstract][Full Text] [Related]
50. Viral, genetic, and immune factors in the oncogenesis of adult T-cell leukemia/lymphoma.
Yasunaga JI
Int J Hematol; 2023 Apr; 117(4):504-511. PubMed ID: 36705848
[TBL] [Abstract][Full Text] [Related]
51. Interferon alfa and antiretroviral agents: a treatment option for adult T-cell leukemia/lymphoma.
Ishitsuka K; Tsukasaki K; Tamura K
Drugs Today (Barc); 2011 Aug; 47(8):615-23. PubMed ID: 21850284
[TBL] [Abstract][Full Text] [Related]
52. [Mechanism of oncogenesis by human T-cell leukemia virus type 1].
Matsuoka M
Gan To Kagaku Ryoho; 2010 Jan; 37(1):10-3. PubMed ID: 20087027
[TBL] [Abstract][Full Text] [Related]
53. Clinical trials for human T-cell lymphotropic virus type I-associated peripheral T-cell lymphoma in Japan.
Tobinai K
Semin Hematol; 2010 Apr; 47 Suppl 1():S5-7. PubMed ID: 20359583
[TBL] [Abstract][Full Text] [Related]
54. Immunological risks of adult T-cell leukemia at primary HTLV-I infection.
Kannagi M; Ohashi T; Harashima N; Hanabuchi S; Hasegawa A
Trends Microbiol; 2004 Jul; 12(7):346-52. PubMed ID: 15223062
[TBL] [Abstract][Full Text] [Related]
55. Adult T-cell leukemia/lymphoma (ATL) presenting in the skin: clinical, histological and immunohistochemical features of 52 cases.
Bittencourt AL; Barbosa HS; Vieira MD; Farré L
Acta Oncol; 2009; 48(4):598-604. PubMed ID: 19165640
[TBL] [Abstract][Full Text] [Related]
56. A case series of adult T-cell leukemia-lymphoma, associated with human T-cell leukemia virus type-1, at a single center in a non-viral-endemic metropolitan area.
Akuzawa Y; Tsukasaki K; Saeki T; Okamura D; Ishikawa M; Maeda T; Kohri M; Takahashi N; Matsuda A; Kawai N; Asou N
J Clin Exp Hematop; 2019; 59(3):108-111. PubMed ID: 31564712
[TBL] [Abstract][Full Text] [Related]
57. HTLV-I viral escape and host genetic changes in the development of adult T cell leukemia.
Furukawa Y; Tara M; Izumo S; Arimura K; Osame M
Int J Cancer; 2006 Jan; 118(2):381-7. PubMed ID: 16052518
[TBL] [Abstract][Full Text] [Related]
58. How I treat adult T-cell leukemia/lymphoma.
Bazarbachi A; Suarez F; Fields P; Hermine O
Blood; 2011 Aug; 118(7):1736-45. PubMed ID: 21673346
[TBL] [Abstract][Full Text] [Related]
59. [Clinico-pathological aspects of adult T-cell leukemia/lymphoma(ATL)].
Fujimoto T; Yamada Y
Nihon Rinsho; 2000 Mar; 58(3):655-9. PubMed ID: 10741141
[TBL] [Abstract][Full Text] [Related]
60. Advanced human T-cell leukemia virus type 1 carriers and early-stage indolent adult T-cell leukemia-lymphoma are indistinguishable based on CADM1 positivity in flow cytometry.
Kobayashi S; Watanabe E; Ishigaki T; Ohno N; Yuji K; Nakano K; Yamochi T; Watanabe N; Tojo A; Watanabe T; Uchimaru K
Cancer Sci; 2015 May; 106(5):598-603. PubMed ID: 25703103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
